Skip to main content
Clinical Trials/NCT04291911
NCT04291911CompletedNot Applicable

Prospective Multicentre Observational Study on the Incidence of Hyperoxia in Non-intubated Patients in Intensive Care in Belgium Study OxSIZgen

SIZ Nursing1 site in 1 country300 target enrollmentStarted: September 21, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
300
Locations
1
Primary Endpoint
INCIDENCE HYPEROXIA

Study Overview

Brief Summary

Oxygen is the most widely prescribed therapy in the ICU (intensive care unit) and can save lives in critical patients. While the deleterious effects of hypoxia are apparent and must be actively avoided, hyperoxia also has adverse effects. These include systemic, coronary and cerebral vasoconstriction; decreased coronary blood flow; pulmonary atelectasis and increased free radicals. Despite these deleterious effects, hyperoxia is common and frequent in the ICU (from 22% to 74%).

A recent meta-analysis published in "The Lancet" with more than 16,000 patients demonstrated an association between liberal oxygen therapy and mortality in critical patients. Other meta-analyses confirm its results with high quality data according to the authors.

A randomized controlled trial published in "The New England Journal of Medicine" comparing liberal versus conservative oxygen therapy showed no difference in mechanical ventilation days and mortality (The ICU-ROX, 2019). However, the difference in PaO2 between the two groups was very small and the PaO2 in the liberal group did not exceed 100 mmHg. In any case, conservative oxygen therapy is safe for critical patients.

The recommendations therefore recommend an oxygen saturation between 94-97% in critical patients and 88-92% in patients with COPD (Chronic Obstructive Pulmonary Disease) .

However, to our knowledge, no study has described the incidence of hyperoxia in non-intubated patients in the intensive care unit.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patient having oxygen
  • Not to be ventilated
  • Being over 18 years old

Exclusion Criteria

  • Sickle cell disease patient
  • Patient with pneumo/hemothorax
  • Pregnant women, prisoners, denial of informed consent
  • Patients who are related to an investigator
  • Patients undergoing hyperbaric chamber therapy
  • Patients with CO
  • Patients on ECMO
  • Patients with paracoate poisoning...
  • Patients included in other interventional studies

Outcomes

Primary Outcomes

INCIDENCE HYPEROXIA

Time Frame: one week

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
SIZ Nursing
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Arnaud Bruyneel

President of SIZ Nursing, RN, CCRN, PhDc

SIZ Nursing

Study Sites (1)

Loading locations...

Similar Trials